Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The apolipoprotein story.

Frank M Sacks1

  • 1Department of Nutrition, Harvard School of Public Health, Boston, MA, USA. fsacks@hsph.harvard.edu

Atherosclerosis. Supplements
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Apolipoprotein B (apo B) is a superior predictor of cardiac events compared to LDL cholesterol, even during statin therapy. Triglycerides and apo C-III also offer valuable insights into coronary heart disease (CHD) risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Dietary Carbohydrate Amount and Glycemic Index on Blood Lipidomic Signatures and Diurnal Postprandial Glucose Responses: The OmniCarb Trial.

Diabetes·2026
Same author

Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial.

Journal of Alzheimer's disease : JAD·2026
Same author

Partially Replacing Dietary Carbohydrate With Unsaturated Fat or Protein Shifts Protein-Based HDL Subspecies Toward Lower Coronary Heart Disease Risk.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Effect modifiers of the MIND diet for cognition in older adults: The MIND diet trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Effect of weight loss through dietary interventions on cardiometabolic health in older adults.

International journal of obesity (2005)·2025
Same author

Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial.

The American journal of clinical nutrition·2025
Same journal

'Diet and lifestyle' in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members.

Atherosclerosis. Supplements·2021
Same journal

Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool.

Atherosclerosis. Supplements·2021
Same journal

Lipid Clinics Network. Rationale and design of the EAS global project.

Atherosclerosis. Supplements·2021
Same journal

Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives.

Atherosclerosis. Supplements·2021
Same journal

Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project.

Atherosclerosis. Supplements·2021
Same journal

Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies.

Atherosclerosis. Supplements·2021
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Preventive Cardiology

Background:

  • The predictive value of various lipid and lipoprotein measurements for cardiac events is debated.
  • Apolipoproteins, triglycerides, and LDL particle concentration are key areas of interest.

Purpose of the Study:

  • To evaluate the role of apolipoprotein B (apo B) as an independent predictor of coronary heart disease (CHD).
  • To compare the predictive efficacy of apo B against LDL and non-HDL cholesterol.
  • To assess the contribution of triglycerides and apo C-III in CHD risk prediction.

Main Methods:

  • Analysis of existing epidemiological data and clinical studies.
  • Comparison of predictive performance of different biomarkers including apo B, triglycerides, LDL, and non-HDL cholesterol.

Related Experiment Videos

  • Evaluation of biomarker performance during statin treatment.

    • Main Results:

    • Apolipoprotein B (apo B) is a strong, independent predictor of initial and recurrent coronary events, outperforming LDL and non-HDL cholesterol.
    • Apo B measurement is unaffected by fasting status or hypertriglyceridemia.
    • Triglycerides and triglyceride-rich lipoproteins, particularly with apo C-III, also show strong predictive value and may offer additional information beyond apo B.

    Conclusions:

    • Apolipoprotein B (apo B) offers significant advantages as a predictor of CHD risk due to its independent predictive power and measurement stability.
    • Triglycerides and apo C-III provide valuable complementary information for CHD risk assessment.
    • Further research and clinical application of apo B and triglyceride-related markers are warranted for improved CHD risk prediction and treatment response evaluation.